biostudies-literatureMac Donald-Ottevanger MSRIVMAGIS197-204https://www.ebi.ac.uk/biostudies/studies/S-EPMC9977238biostudies-literatureUnknown117(3)<h4>Background</h4>Hepatitis A virus (HAV) and hepatitis E virus (HEV) have enteric modes of transmission and are common causes of acute hepatitis in low- and middle-income countries. HEV is also characterised as a zoonotic infection and is prevalent in high-income countries. Data on HAV and HEV prevalence in Suriname, a middle-income country in South America, are scarce.<h4>Methods</h4>Serum samples of 944 and 949 randomly selected patients attending the Emergency Department at the Academic Hospital of Paramaribo, the capital of Suriname, were analysed for anti-HAV antibodies (anti-HAV) and anti-HEV antibodies (anti-HEV), respectively. Determinants of anti-HAV and anti-HEV positive serology were evaluated using multivariable logistic regression.<h4>Results</h4>Anti-HAV prevalence was 58.3Transactions of the Royal Society of Tropical Medicine and HygieneEthnic differences in hepatitis A and E virus seroprevalence in patients attending the Emergency Department, Paramaribo, Suriname.PMC9977238499263Mac Donald-Ottevanger MSVreden SGSvan Dissel JRier NReimerink JZijlmans WCWRBoyd APrins MfalseEthnic differences in hepatitis A and E virus seroprevalence in patients attending the Emergency Department, Paramaribo, Suriname.<h4>Background</h4>Hepatitis A virus (HAV) and hepatitis E virus (HEV) have enteric modes of transmission and are common causes of acute hepatitis in low- and middle-income countries. HEV is also characterised as a zoonotic infection and is prevalent in high-income countries. Data on HAV and HEV prevalence in Suriname, a middle-income country in South America, are scarce.<h4>Methods</h4>Serum samples of 944 and 949 randomly selected patients attending the Emergency Department at the Academic Hospital of Paramaribo, the capital of Suriname, were analysed for anti-HAV antibodies (anti-HAV) and anti-HEV antibodies (anti-HEV), respectively. Determinants of anti-HAV and anti-HEV positive serology were evaluated using multivariable logistic regression.<h4>Results</h4>Anti-HAV prevalence was 58.32023-01-01T00:00:00Z2023 Mar2025-05-18T12:55:09.585Z2025-04-05T13:01:24.701ZS-EPMC99772383635397310.1093/trstmh/trac101